电针加温针治疗足跟痛:随机等待对照试验
这项在中国香港中医中心开展的随机等待对照试验纳入80例足跟痛患者,治疗组接受4周共6次标准化电针加温针治疗,对照组等待。
要点
- 电针加温针可改善中老年足跟痛患者第一步疼痛与足功能。
- 4周内6次治疗即见组间显著差异,疗效持续至第8周。
- 试验期间未报告研究相关不良事件。
核心结论
- 电针加温针治疗可能对中老年足跟痛有效。
研究设计与样本
- 前瞻性随机平行组等待对照试验,2018年5月至2019年2月在香港中医中心开展。
- 80例符合条件社区足跟痛患者均等随机分为电针加温针组与等待组,平均年龄59.7岁,85%为女性。
- 治疗组4周内接受6次30分钟标准化电针加温针治疗,对照组不接受治疗。
主要发现
- 第2周和第4周治疗组第一步疼痛VAS均值及全部足功能指数评分改善均显著优于对照组(均P<0.001)。
- 治疗组第2周和第4周第一步疼痛VAS均值较基线显著下降,第4周足功能指数评分较基线显著下降,对照组无显著变化。
- 治疗组改善持续至第8周;第4周整体变化评分显示全部治疗患者改善,对照组仅22.5%改善(P<0.001)。
- 未发生研究相关不良事件。
关键数值与推荐
- 主要终点为第4周,评估工具包括第一步疼痛VAS、足功能指数和整体变化评分。
- 分析采用意向性治疗分析。
临床怎么用
- 可考虑将电针加温针作为中老年足跟痛的治疗选择之一。
- 疗程可参考4周内6次、每次30分钟的标准化方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the therapeutic effects of electroacupuncture plus warm needling (EAWN) therapy on pain and foot function in adults with plantar heel pain (PHP). METHODS: This prospective, randomised, parallel-group, waitlist-controlled trial was conducted at a Chinese medicine centre in Hong Kong between May 2018 and February 2019. Eighty eligible community-dwelling subjects with PHP (mean age 59.7 years; 85% female) were equally randomised to receive EAWN therapy or remain on a waitlist. The treatment group received six 30-min sessions of standardised EAWN therapy over 4 weeks; the control group received no treatment. The outcome measures were the visual analogue scale (VAS) score for first-step pain, foot function index (FFI) scores and global rating of change (GRC) scale scores. Assessments were made at baseline, week 2 and week 4 (primary endpoint). The treatment group underwent additional assessments at week 8. Outcomes were evaluated by intention-to-treat analysis. RESULTS: Patients who received EAWN therapy exhibited greater improvements in the mean first-step pain VAS and all FFI scores than did those in the control group at weeks 2 and 4, with significant between-group differences (all P < 0.001). Compared with baseline, there were significant decreases in mean first-step pain VAS scores at weeks 2 and 4, and FFI scores at week 4, in the treatment group but not in the control group. The improvements in the treatment group continued until week 8. GRC scores at week 4 indicated improvement in all treated patients and only 22.5% of the control group patients (P < 0.001). There were no study-related adverse events. CONCLUSION: EAWN therapy could be an effective treatment for PHP in middle-aged and older adults. TRIAL REGISTRATION NUMBER: ChiCTR1800014906 (Chinese Clinical Trials Registry).
引用
- Ho LF, Guo Y, Ching JY, et al. Efficacy of electroacupuncture plus warm needling therapy for plantar heel pain: a randomised waitlist-controlled trial. Acupunct Med. 2020. PMID: 32815386. doi:10.1177/0964528420946048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。